Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of central nervous system disorders with selective estrogen receptor modulators

Treatment of central nervous system disorders with selective estrogen receptor modulators

US Patent 6077852 · Granted Jun 20, 2000

Estimated economic value: $939,768,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions for the treatment of disease2022
Compositions for the treatment of disease2022
Assay method for Alzheimer's disease2016
Assay method for Alzheimer's disease2016
Humanized antibodies that sequester amyloid beta peptide2013
Humanized antibodies that sequester amyloid beta peptide2013
Assay method for Alzheimer's disease2013
Assay method for Alzheimer's disease2013
Humanized antibodies that sequester amyloid beta peptide2011
Humanized antibodies that sequester amyloid beta peptide2011
Assay method for alzheimer's disease2010
Assay method for alzheimer's disease2010